Zydus receives final approval from the USFDA for Acyclovir Cream

he product will be launched shortly in the US market.

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event

Merck and AstraZeneca updates on US regulatory review of Lynparza for mCRPC

AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.

ProBioGen’s growth strategy continues successfully

Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team

Vaishali Pharma bags Rs 600 crore order for antibiotics pharmaceutical products

This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.

Dr. Reddy's Laboratories to acquire Mayne Pharma’s U.S. generic prescription product portfolio

The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.

Vaishali Pharma receives multiple orders worth US$ 73.85 million

This order is subject to initial advance payment as per the agreed terms of the contract

Alembic gets USFDA final approval for ANDA Docetaxel Injection

Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi

The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region

Sanofi reaffirms commitment to rare diseases in India

Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India